Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02778880 · ClinicalTrials.gov registry record · Phase 3
Pain Reduction With Intranasal Medications for Extremity Injuries
A Phase 3 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 90
- Enrollment target
NCT02778880 is a Phase 3 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 90 participants.
The verdict
NCT02778880, a Phase 3 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study compares the analgesic effect of intranasal sub-dissociative dosing of ketamine and intranasal fentanyl in children presenting to the Emergency Department with acute extremity injuries.
Interventions
- DRUG Ketamine
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2016-03-31 |
| Est. Completion | 2017-03-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02778880
The ClinicalTrials.gov registry entry for NCT02778880 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02778880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02778880 about?
NCT02778880 is a clinical study titled "Pain Reduction With Intranasal Medications for Extremity Injuries". This study compares the analgesic effect of intranasal sub-dissociative dosing of ketamine and intranasal fentanyl in children presenting to the Emergency Department with acute extremity injuries.
What is the current status of trial NCT02778880?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2016-03-31. Estimated completion is 2017-03-21.
What interventions are being tested in trial NCT02778880?
The interventions under investigation include: Ketamine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT02778880?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.